This is a news story, published by Digital Market Reports, that relates primarily to Kyoto University Hospital news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Digital Market Reports, you can click here:
more news from Digital Market ReportsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
tooth growth. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest tooth loss news, human dentition news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
new tooth developmentDigital Market Reports
•82% Informative
Kyoto University Hospital is scheduled to begin the world’s first human trial of a tooth-regrowing drug this September .
This trial follows promising results in animal studies and could lead to the drug being commercially available by 2030 .
The drug operates by deactivating the uterine sensitization-associated gene-1 (USAG-1) protein, which has been identified as an inhibitor of tooth growth.
VR Score
81
Informative language
82
Neutral language
6
Article tone
formal
Language
English
Language complexity
64
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
11
Affiliate links
no affiliate links